Sep 13, 2023 / 02:50PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. Biopharma Analyst here at Morgan Stanley. Very pleased to be hosting AbbVie this morning for the session. Today, joining us from the company, we have Rob Michael, President and COO; Scott Reents, who's CFO; Jeff Stewart, CCO; and Roopal Thakkar, who is Head of Development and Regulatory Affairs and CMO. But thank you so much all for being here. Really appreciate the time.
Robert A. Michael - AbbVie Inc. - President & COO
Thanks for having us.
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Before we get started for disclosures, please see Morgan Stanley's research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. With that out of the way. Maybe Rob will go over
Abbvie Inc at Morgan Stanley Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot